Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6‐mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity-Reference-Cited by-同舟云学术

Allopurinol use during pediatric acute lymphoblastic leukemia maintenance therapy safely corrects skewed 6‐mercaptopurine metabolism, improving inadequate myelosuppression and reducing gastrointestinal toxicity

Published:2020-09-10 Issue:11 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Cohen Gordon¹,Cooper Stacy¹^ORCID,Sison Edward Allan²,Annesley Colleen³,Bhuiyan Mariam⁴,Brown Patrick¹

Affiliation:

1. Division of Pediatric Oncology, Department of Oncology Johns Hopkins University School of Medicine Baltimore Maryland

2. Section of Hematology‐Oncology, Department of Pediatrics, Baylor College of Medicine Texas Children's Cancer and Hematology Centers Houston Texas

3. Department of Pediatrics Seattle Children's Hospital, University of Washington Seattle Washington

4. Johns Hopkins University School of Medicine Baltimore Maryland

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28360

Reference17 articles.

1. Intensification of mercaptopurine/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia;Kjeld S;J Clin Oncol,2003

2. Inotuzumab ozogamicin and frontline chemotherapy in treating young adults with newly diagnosed B acute lymphoblastic leukemia. ClinicalTrials.gov. Accessed 20 Mar2018.

3. Efficacy and safety of imatinib on top of BFM‐like chemotherapy in pediatric patients with ph+/BCR‐ABL+ acute lymphoblastic leukemia (Ph+ALL). The EsPhALL study;Biondi A;Blood,2011

4. Children's Oncology Group AALL0932“Treatment of patients with newly diagnosed standard risk B‐lymphoblastic leukemia (B‐ALL) or Localized B‐lineage lymphoblastic lymphoma” version data 10/26/2017.

5. Treatment of acute lymphoblastic leukemia in adults

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of allopurinol to manage skewed 6‐mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment;European Journal of Haematology;2024-07-11

2. Chemotherapeutic metabolism presenting as a recalcitrant case of hand–foot syndrome and mucositis;Journal of Oncology Pharmacy Practice;2024-01-10

3. Hybrid Email and Outpatient Clinics to Optimize Maintenance Therapy in Acute Lymphoblastic Leukemia;Journal of Pediatric Hematology/Oncology;2023-12-12

4. Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor;Molecular Cancer Therapeutics;2023-08-24

5. Significant erythroid megaloblastic changes in patients treated with allopurinol during maintenance chemotherapy for acute lymphoblastic leukemia;Pediatric Blood & Cancer;2023-08-14